This cause is very personal for me because my future depends on innovative research and new treatments for blood cancers. In January 2020, on the eve of the global pandemic, I was diagnosed with stage IV Non-Hodgkins Lymphoma. I responded well to treatment and have been in remission for two years. However, the subtype I was diagnosed with comes back and can become more aggressive over time. So for me, a continuous effort to find the big “C” is critical! My amazing hematologist-oncologist agrees - and I feel confident in my care because he is also passionate about research and investing in new treatment options. Immunotherapy was part of my initial treatment and I feel strongly that more developments in this area will yield more treatment options and better ultimately outcomes for patients. My infusion nurses often remarked to me how they have seen quality of life dramatically improve for patients as more immunotherapy options have become available. The progress is inspiring. From blood cancer to solid organ tumors, immunotherapy treatments such as monoclonal antibodies, CAR-T and bispecifics are changing the treatment landscape for cancer patients. But the work is not done until there is a cure for all cancers, including Non-Hodgkins Lymphoma. Participation in VeloSano gives me a sense of hope. My children also participate and I love watching them advocate for a cause and look for creative ways to increase contributions for our team. From lemonade stands to baseball snacks, their ideas and dedication are inspiring!